Körber has launched a manufacturing execution system (MES) designed for smaller pharmaceutical sites, where the scale of a full MES implementation can be a barrier to replacing paper-based processes.
The software, PAS-X Neo, is aimed at small and medium-sized manufacturers, as well as smaller facilities within larger organisations. Körber says standardised process templates help support an implementation time of around two months.
Delivered as fully managed software as a service (SaaS), the system does not require any local infrastructure to run. Körber says pre-validated components reduce validation work. Features include audit trails and electronic signatures, with controls designed to support data integrity and compliance with US and European requirements for electronic records.
The system was launched on 11 November 2026 at the Biotech & Medical Device World Summit in San Diego, following its initial announcement in May. Manufacturers can add capabilities as operations expand, with the possibility to scale up to Körber’s PAS-X MES platform if required.
Körber has previously used hardware partnerships to simplify deployment of its existing PAS-X MES. In September 2025, it announced a collaboration with Pepperl+Fuchs covering VisuNet human-machine interfaces, which allow operators to use the software in cleanrooms and hazardous production areas. The companies developed joint installation recommendations designed to help reduce manual configuration work.